Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

A piece of my mind. Water, water, everywhere.

Farel CE.

JAMA. 2014 Jul 23-30;312(4):343-4. doi: 10.1001/jama.2014.2646. No abstract available.

PMID:
25038349
2.

Namibian prisoners describe barriers to HIV antiretroviral therapy adherence.

Shalihu N, Pretorius L, van Dyk A, Vander Stoep A, Hagopian A.

AIDS Care. 2014;26(8):968-75. doi: 10.1080/09540121.2014.880398. Epub 2014 Feb 6.

PMID:
24499371
3.

A piece of my mind. Forever young.

Chisty A.

JAMA. 2012 Jul 25;308(4):351-2. doi: 10.1001/jama.2012.8883. No abstract available.

PMID:
22820787
4.

Balancing adherence concerns with the risks of HIV disease progression.

Johnson SC.

Clin Infect Dis. 2009 Mar 15;48(6):827-8. doi: 10.1086/596769. No abstract available.

PMID:
19191604
5.

Prisons. Records show inmate received HIV medication but refused it.

[No authors listed]

AIDS Policy Law. 2011 Sep;26(10):6. No abstract available.

PMID:
22003530
6.

[Factors related to refuse antiretroviral therapy in prison].

Sordo del Castillo L, Ruiz Pérez I, Olry Labry de Lima A, Soto Blanco JM, Antón Basanta JJ, Girela López E, Castro Recio JM.

Gac Sanit. 2008 Mar-Apr;22(2):120-7. Spanish.

7.

Adherence to antiretroviral therapy among HIV-infected prisoners.

Paparizos V, Kourkounti S, Leuow K, Georgoulas S, Kyriakis K, Antoniou C.

Infez Med. 2013 Sep;21(3):189-93.

8.

Violence and the perceived risks of taking antiretroviral therapy in US jails and prisons.

Culbert GJ.

Int J Prison Health. 2014;10(2):94-110. doi: 10.1108/IJPH-05-2013-0020.

9.

Non-placebo controlled HIV experimental trials in prisoners.

Bellin E.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 1;9(3):315-6. No abstract available.

PMID:
7788435
10.

The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients.

Chandok N, John S, Haider S.

Ann Hepatol. 2011 Jan-Mar;10(1):103-4. No abstract available.

11.

Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail.

Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL.

AIDS Behav. 2013 Oct;17 Suppl 2:S118-27. doi: 10.1007/s10461-013-0506-0.

12.

Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.

Taylor LE, Schwartzapfel B, Allen S, Jacobs G, Mitty J.

Clin Infect Dis. 2003 Jun 1;36(11):1501-2; author reply 1502-3. No abstract available.

PMID:
12766851
13.

Adherence to HIV drug therapy.

Gross R.

LDI Issue Brief. 2002 Nov;8(3):1-4.

PMID:
12530426
14.

Red ribbon.

Wright PW.

Tex Heart Inst J. 2013;40(4):384. No abstract available.

15.

Psychosocial aspects of antiretroviral medication use among HIV patients.

Aversa SL, Kimberlin C.

Patient Educ Couns. 1996 Nov;29(2):207-19.

PMID:
9006237
16.

Severe psoriasis due to cessation of antiretroviral therapy in a patient with human immunodeficiency virus.

Vano-Galvan S, Jaen P.

Isr Med Assoc J. 2008 Jul;10(7):557-8. No abstract available.

17.

Adherence to antiviral therapy in HIV or HBV-infected patients.

Wójcik K, Piekarska A, Jabłonowska E.

Przegl Epidemiol. 2016;70(1):27-32, 115-8. English, Polish.

18.

Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.

White BL, Golin CE, Grodensky CA, Kiziah CN, Richardson A, Hudgens MG, Wohl DA, Kaplan AH.

AIDS Behav. 2015 Jan;19(1):128-36. doi: 10.1007/s10461-014-0850-8.

19.

The link between religion and HAART adherence in pediatric HIV patients.

Park J, Nachman S.

AIDS Care. 2010 May;22(5):556-61. doi: 10.1080/09540120903254013.

PMID:
20397076
20.

Supplemental Content

Support Center